The Trump administration’s push to bring US drug spending down is a powerful incentive for pharmaceutical companies to boost prices and reduce access elsewhere in the world, a study found.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-09-13/trump-s-drug-pricing-push-to-cut-access-outside-us-study-finds)